Target Group Inc. (CBDY)

↓ Download CSV

CIK 0001586554 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Target Group Inc. reported revenue of $3.88M, down 41.1% from the prior year. The company ran a net loss, with a net margin of -35.0% and a gross margin of 53.3%. It held $6.18M in total assets against $14.24M in total liabilities.

Key ratios (FY2025)

53.3%
Gross margin
-35.0%
Net margin
-41.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$3.88M$6.59M$3.72M$0$0$30.0K$0$263
Cost of Revenue$1.81M$2.87M$2.07M$0$25.0K$0
Gross Profit$2.07M$3.73M$1.66M$0$5.0K$0
Net Income-$1.36M$160.5K-$323.7K-$4.52M$272.9K-$7.07M-$10.37M-$1.90M-$1.74M-$2.34M
EPS (Diluted)$-0.00$0.00$-0.00$-0.01$0.00$-0.01
Total Assets$6.18M$7.57M$8.84M$7.57M$13.06M$13.04M$16.46M$6.78M$56$293.9K
Total Liabilities$14.24M$14.08M$15.81M$14.13M$15.22M$16.56M$12.68M$3.44M$2.06M$2.11M
Shareholders' Equity-$8.06M-$6.51M-$6.97M-$6.56M-$2.15M-$3.52M$3.79M$3.34M-$2.06M-$1.82M
Cash & Equivalents$10.5K$303.4K$56$16.3K
Operating Cash Flow-$842.4K$2.16M-$589.6K-$1.01M$100.1K-$1.43M-$5.52M-$699.5K-$262.1K-$421.0K
Capital Expenditures$42.5K$3.51M
Shares Outstanding617.03M617.03M617.03M617.03M617.03M573.28M571.15M93.62M14.97M35.6K